152 related articles for article (PubMed ID: 30801864)
1. Regulation of programmed cell death ligand 1 expression by atypical protein kinase C lambda/iota in cutaneous angiosarcoma.
Kawamura A; Kawamura T; Riddell M; Hikita T; Yanagi T; Umemura H; Nakayama M
Cancer Sci; 2019 May; 110(5):1780-1789. PubMed ID: 30801864
[TBL] [Abstract][Full Text] [Related]
2. aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability.
Riddell M; Nakayama A; Hikita T; Mirzapourshafiyi F; Kawamura T; Pasha A; Li M; Masuzawa M; Looso M; Steinbacher T; Ebnet K; Potente M; Hirose T; Ohno S; Fleming I; Gattenlöhner S; Aung PP; Phung T; Yamasaki O; Yanagi T; Umemura H; Nakayama M
Nat Commun; 2018 Dec; 9(1):5357. PubMed ID: 30559384
[TBL] [Abstract][Full Text] [Related]
3. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus-triggered PTEN/β-catenin/c-Myc signaling enhances PD-L1 expression to promote immune evasion.
Sun Y; Yu M; Qu M; Ma Y; Zheng D; Yue Y; Guo S; Tang L; Li G; Zheng W; Wang M; Guo D; Li C
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G162-G173. PubMed ID: 31604033
[TBL] [Abstract][Full Text] [Related]
5. Analysis of PD-1, PD-L1, and T-cell infiltration in angiosarcoma pathogenetic subgroups.
Tomassen T; Weidema ME; Hillebrandt-Roeffen MHS; van der Horst C; ; Desar IME; Flucke UE; Versleijen-Jonkers YMH
Immunol Res; 2022 Apr; 70(2):256-268. PubMed ID: 35043369
[TBL] [Abstract][Full Text] [Related]
6. Expression and clinical significance of PD-L1 and c-Myc in non-small cell lung cancer.
Zhou C; Che G; Zheng X; Qiu J; Xie Z; Cong Y; Pei X; Zhang H; Sun H; Ma H
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2663-2674. PubMed ID: 31541338
[TBL] [Abstract][Full Text] [Related]
7. Atypical Protein Kinase C λ/ι Expression Is Associated with Malignancy of Oral Squamous Cell Carcinoma.
Baba J; Kioi M; Akimoto K; Nagashima Y; Taguri M; Inayama Y; Aoki I; Ohno S; Mitsudo K; Tohnai I
Anticancer Res; 2018 Nov; 38(11):6291-6297. PubMed ID: 30396949
[TBL] [Abstract][Full Text] [Related]
8. MYC regulates the antitumor immune response through CD47 and PD-L1.
Casey SC; Tong L; Li Y; Do R; Walz S; Fitzgerald KN; Gouw AM; Baylot V; Gütgemann I; Eilers M; Felsher DW
Science; 2016 Apr; 352(6282):227-31. PubMed ID: 26966191
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 Expression in Cutaneous Angiosarcomas: A Systematic Review with Meta-Analysis.
Lobrano R; Paliogiannis P; Zinellu A; Palmieri G; Persico I; Mangoni AA; Cossu A
Curr Oncol; 2023 May; 30(5):5135-5144. PubMed ID: 37232846
[TBL] [Abstract][Full Text] [Related]
10. Expression of Programmed Cell Death Proteins in Kaposi Sarcoma and Cutaneous Angiosarcoma.
Gambichler T; Koim S; Wrobel M; Käfferlein HU; Brüning T; Stockfleth E; Becker JC; Lang K
J Immunother; 2020 Jun; 43(5):169-174. PubMed ID: 32224717
[TBL] [Abstract][Full Text] [Related]
11. Far upstream element-binding protein 1 is up-regulated in pancreatic cancer and modulates immune response by increasing programmed death ligand 1.
Fan P; Ma J; Jin X
Biochem Biophys Res Commun; 2018 Nov; 505(3):830-836. PubMed ID: 30301530
[TBL] [Abstract][Full Text] [Related]
12. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.
Homma S; Hayashi K; Yoshida K; Sagawa Y; Kamata Y; Ito M
Int Immunopharmacol; 2018 Jan; 54():39-45. PubMed ID: 29100036
[TBL] [Abstract][Full Text] [Related]
13. MYC expression correlates with PD-L1 expression in non-small cell lung cancer.
Kim EY; Kim A; Kim SK; Chang YS
Lung Cancer; 2017 Aug; 110():63-67. PubMed ID: 28676221
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of PD-L1 expression in colorectal cancer: Impact of PD-L1 expression on pFOXO1 expression.
Pyo JS; Ko SH; Ko YS; Kim NY
Pathol Res Pract; 2020 Feb; 216(2):152764. PubMed ID: 31836325
[TBL] [Abstract][Full Text] [Related]
15. MYC inhibition increases PD-L1 expression induced by IFN-γ in hepatocellular carcinoma cells.
Zou J; Zhuang M; Yu X; Li N; Mao R; Wang Z; Wang J; Wang X; Zhou H; Zhang L; Shi Y
Mol Immunol; 2018 Sep; 101():203-209. PubMed ID: 30007230
[TBL] [Abstract][Full Text] [Related]
16. aPKCλ/ι is a beneficial prognostic marker for pancreatic neoplasms.
Kato S; Akimoto K; Nagashima Y; Ishiguro H; Kubota K; Kobayashi N; Hosono K; Watanabe S; Sekino Y; Sato T; Sasaki K; Nakaigawa N; Kubota Y; Inayama Y; Endo I; Ohno S; Maeda S; Nakajima A
Pancreatology; 2013; 13(4):360-8. PubMed ID: 23890134
[TBL] [Abstract][Full Text] [Related]
17. BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR/MAPK signaling pathways in non-small cell lung cancer.
Wang J; Jia Y; Zhao S; Zhang X; Wang X; Han X; Wang Y; Ma M; Shi J; Liu L
Oncogene; 2017 Nov; 36(45):6235-6243. PubMed ID: 28714960
[TBL] [Abstract][Full Text] [Related]
18. EGFR activation induced Snail-dependent EMT and myc-dependent PD-L1 in human salivary adenoid cystic carcinoma cells.
Wang Y; Hu J; Wang Y; Ye W; Zhang X; Ju H; Xu D; Liu L; Ye D; Zhang L; Zhu D; Deng J; Zhang Z; Liu S
Cell Cycle; 2018; 17(12):1457-1470. PubMed ID: 29954240
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor-1α and nuclear factor-κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non-small-cell lung cancer cells.
Guo R; Li Y; Wang Z; Bai H; Duan J; Wang S; Wang L; Wang J
Cancer Sci; 2019 May; 110(5):1665-1675. PubMed ID: 30844110
[TBL] [Abstract][Full Text] [Related]
20. High expression of atypical protein kinase C lambda/iota in gastric cancer as a prognostic factor for recurrence.
Takagawa R; Akimoto K; Ichikawa Y; Akiyama H; Kojima Y; Ishiguro H; Inayama Y; Aoki I; Kunisaki C; Endo I; Nagashima Y; Ohno S
Ann Surg Oncol; 2010 Jan; 17(1):81-8. PubMed ID: 19774416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
